FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in Seattle, United States

Biotech startups that raised Series B in Seattle, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in Seattle, United States
One-time CSV
  • 23 funded companies, 21 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~seattle-washington.csv23 rows × 18 columns
CompanyCityLast roundAmountDate
InduProSeattleSeries B$77.0M2026-08-12
Curi BioSeattleSeries B$10.0M2025-12-02
Outpace BioSeattleSeries B$144.0M2024-08-01
ProfoundBioSeattleSeries B$112.0M2024-02-13
PronirasSeattleSeries B$4.7M2024-02-01
PhytelligenceSeattleSeries B$9.8M2018-07-09

6 rows of the CSV in 5 of its 18 columns.

23
Startups
$1.8B
Total raised
2
Funded in the last 12 months
$87.0M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

2 of 23
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
InduPro InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. Biotech Series B $77.0M 2026-08-12 $162.0M Euclidean Capital, The Column Group, Vida Ventures +1 51 to 100 2022
Curi Bio Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. Artificial intelligence Series B $10.0M 2025-12-02 $30.4M National Institutes of Health, Dynamk Capital 11 to 50 2015

Table 1. Biotech startups that raised Series B in Seattle, United States: the 2 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 InduPro InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. Biotech Series B $77.0M 2026-08-12 $162.0M Euclidean Capital, The Column Group, Vida Ventures +1 51 to 100 2022
2 Curi Bio Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. Artificial intelligence Series B $10.0M 2025-12-02 $30.4M National Institutes of Health, Dynamk Capital 11 to 50 2015

Table 2. Biotech startups that raised Series B in Seattle, United States: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 RA Capital Management Startup incubator Boston, United States 2 9%
2 Alexandria Venture Investments Venture capital firm Pasadena, United States 2 9%
3 OrbiMed Private equity firm New York, United States 2 9%
4 Euclidean Capital Family office New York, United States 1 4% 1 InduPro
5 MRL Ventures Fund Corporate venture arm Cambridge, United States 1 4% 1 InduPro
6 Vida Ventures Venture capital firm Boston, United States 1 4% 1 InduPro
7 The Column Group Venture capital firm San Francisco, United States 1 4% 1 InduPro
8 National Institutes of Health Entrepreneurship program Bethesda, United States 1 4% 1 Curi Bio
9 Dynamk Capital Startup accelerator New York, United States 1 4% 1 Curi Bio
10 Bristol-Myers Squibb Venture capital firm New York, United States 1 4%
11 Abstract Venture capital firm San Francisco, United States 1 4%
12 Agent Capital Venture capital firm Waltham, United States 1 4%
13 Alumni Ventures Angel group Manchester, United States 1 4%
14 iSelect Fund Private equity firm St Louis, United States 1 4%
15 T. Rowe Price Private equity firm Baltimore, United States 1 4%

Table 3. Biotech startups that raised Series B in Seattle, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 22 96% $1.7B
Software 3 13% $102.5M
Artificial intelligence 1 4% $30.4M

Table 4. Biotech startups that raised Series B in Seattle, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 23 100% $20.0M

Table 5. Biotech startups that raised Series B in Seattle, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
August 2026 1 50% $77.0M
December 2025 1 50% $10.0M

Table 6. Biotech startups that raised Series B in Seattle, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 1 4% $77.0M
2025 1 4% $10.0M
2024 4 17% $260.6M
2023 1 4% $52.9M
2021 3 13% $115.0M
2019 1 4% $37.0M

Table 7. Biotech startups that raised Series B in Seattle, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 2 9%
2015 to 2019 8 35%
2010 to 2014 5 22%
Before 2010 8 35%

Table 8. Biotech startups that raised Series B in Seattle, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 5 22%
11 to 50 11 48%
51 to 100 3 13%
101 to 250 2 9%
251 to 500 1 4%
501 to 1,000 1 4%

Table 9. Biotech startups that raised Series B in Seattle, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Seattle, United States whose last round is Series B are on the list?
23, in the file dated 16 November 2026. 2 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in Seattle, United States: 23 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Seattle

Other sectors that raised Series B in Seattle

Cite: FundingWatcher, 23 biotech companies in Seattle, United States whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/seattle-washington/